Stocktoria
Quantum Cyber N.V. QUCY
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-11-04
Quantum Cyber N.V. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Gross margin | 72.6% | 64.3% |
| Operating margin | -3005.0% | -2099.9% |
| Net margin | -3018.3% | -2416.0% |
| FCF margin | -2044.5% | -1950.2% |
| Return on assets | -304.3% | -160.0% |
| Return on equity | -2526.6% | -360.1% |
| Current ratio | 0.90 | 1.30 |
| Revenue growth | -39.9% | — |
Source: SEC EDGAR filings · CIK 0001874252 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.